BetterScholar BetterScholar
10
Role
Title
Level Year L/R
🐜 Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.
11 auth. Maxine Sun, R. Thuret, F. Abdollah, G. Lughezzani, J. Schmitges, Z. Tian, ... S. Shariat, F. Montorsi, J. Patard, P. Perrotte, P. Karakiewicz
8 2011
8
🐜
🐜 Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
49 auth. K. Bensalah, A. Pantuck, N. Rioux-Leclercq, R. Thuret, F. Montorsi, P. Karakiewicz, N. Mottet, L. Zini, R. Bertini, L. Salomon, A. Villers, M. Soulie, L. Bellec, P. Rischmann, A. De la taille, ... R. Avakian, M. Crépel, J. Ferrière, J. Bernhard, T. Dujardin, F. Pouliot, J. Rigaud, C. Pfister, B. Albouy, L. Guy, S. Joniau, H. Van Poppel, T. Lebret, T. Culty, F. Saint, A. Zisman, O. Raz, H. Lang, R. Spie, A. Wille, J. Roigas, A. Aguilera, B. Rambeaud, L. Martínez Piñeiro, O. Nativ, R. Farfara, F. Richard, M. Rouprêt, C. Doehn, P. Bastian, S. C. Muller, J. Tostain, A. Belldegrun, J. Patard
8 2010
8
🐜
🐜 Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis.
13 auth. F. Abdollah, G. Gandaglia, R. Thuret, J. Schmitges, Z. Tian, C. Jeldres, N. Passoni, A. Briganti, S. Shariat, P. Perrotte, ... F. Montorsi, P. Karakiewicz, Maxine Sun
7 2013
7
🐜
🐜 A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006.
11 auth. F. Abdollah, Maxine Sun, R. Thuret, C. Jeldres, Z. Tian, A. Briganti, ... S. Shariat, P. Perrotte, P. Rigatti, F. Montorsi, P. Karakiewicz
7 2011
7
🐜
🐜 Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT?
7 auth. I. Millet, F. C. Doyon, D. Hoa, R. Thuret, S. Mérigeaud, I. Serre, ... P. Taourel
6 2011
6
🐜
🐬 The use of an artificial urinary sphincter in women with type III incontinence and a negative Marshall test.
P. Costa, N. Mottet, Bertrand Rabut, R. Thuret, K. B. Naoum, L. Wagner
6 2001
6
🐬
🐜 Treatment Management of Small Renal Masses in the 21st Century: A Paradigm Shift
11 auth. Maxine Sun, F. Abdollah, M. Bianchi, Q. Trinh, C. Jeldres, R. Thuret, ... Z. Tian, S. Shariat, F. Montorsi, P. Perrotte, P. Karakiewicz
6 2012
6
🐜
🐜 De Novo Kidney Graft Tumors: Results From a Multicentric Retrospective National Study
37 auth. X. Tillou, A. Doerfler, S. Collon, F. Kleinclauss, J. Patard, L. Badet, B. Barrou, M. Audet, H. Bensadoun, E. Berthoux, P. Bigot, J. Boutin, Y. Bouzguenda, D. Chambade, R. Codas, ... J. Dantal, J. Deturmeny, M. Devonec, F. Dugardin, J. Ferrière, A. Erauso, B. Feuillu, M. Gigante, L. Guy, G. Karam, T. Lebret, Y. Neuzillet, C. Legendre, T. Perez, J. Rerolle, L. Salomon, F. Sallusto, C. Senechal, N. Terrier, R. Thuret, G. Verhoest, J. Petit
6 2012
6
🐜
🐜 Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer.
11 auth. F. Abdollah, Maxine Sun, R. Thuret, L. Budäus, C. Jeldres, M. Graefen, ... A. Briganti, P. Perrotte, P. Rigatti, F. Montorsi, P. Karakiewicz
6 2010
6
🐜
🐜 A population‐based competing‐risks analysis of the survival of patients treated with radical cystectomy for bladder cancer
10 auth. G. Lughezzani, Maxine Sun, S. Shariat, L. Budäus, R. Thuret, C. Jeldres, ... D. Liberman, F. Montorsi, P. Perrotte, P. Karakiewicz
6 2011
6
🐜